Table: begin end state 1 20 cytoplasmic 21 41 transmembrane 42 46 non-cytoplasmic 47 65 transmembrane 66 85 cytoplasmic 86 106 transmembrane 107 123 non-cytoplasmic 124 144 transmembrane 145 154 cytoplasmic 155 178 transmembrane 179 198 non-cytoplasmic 199 221 transmembrane 222 240 cytoplasmic 241 262 transmembrane 263 286 non-cytoplasmic 287 308 transmembrane 309 334 cytoplasmic 335 354 transmembrane 355 359 non-cytoplasmic 360 380 transmembrane 381 400 cytoplasmic 401 423 transmembrane 424 428 non-cytoplasmic 429 449 transmembrane 450 463 cytoplasmic
Input: >AO353_12005 MSSIQSSNGLEQGLKPRHVTMLSIAGVIGAGLFVGSGHAIAAAGPAVLLAYAAAGMLVVL VMRMLGEMAVASPDTGSFSTYADRAIGHWAGFTIGWLYWWFWVLVIPLEANAAATILHAW FPNVAIWAFTLIITLLLTVTNLFSVKNYGEFEFWFALIKVLAIIGFIVLGVMAIFGFLPG SQVSGVSHLFDTQGFLPNGMGAVLGAILTTMFSFMGTEIVTIAAAESKNPGQQISKATNS VIWRIGLFYLVSIFIVVALVPWNDPVLASVGSYQTVLERMGIPNAKLIVDLVVLVAVTSC LNSALYTASRMMFSLGKRGDAPAVSQRTNKSGTPYWAVMLSTCAAFLAVFANYVAPAAVF EFLLASSGAIALLVYLVIAISQLRMRKQRMARGEKIAFSMWLFPGLTYAVIVFIVAALTI MLFQDAHRVEILATGLLSLLVVAAGLFVARRRKLEQRGAVVLS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server